Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

• Published in: The European respiratory journal Vol. 56; no. 1; p. 2001398
• Main Authors: Tadolini, Marina, Codecasa, Luigi Ruffo, García-García, José-María, Blanc, François-Xavier, Borisov, Sergey, Alffenaar, Jan-Willem, Andréjak, Claire, Bachez, Pierre, Bart, Pierre-Alexandre, Belilovski, Evgeny, Cardoso-Landivar, José, Centis, Rosella, D'Ambrosio, Lia, Luiza De Souza-Galvão, María-, Dominguez-Castellano, Angel, Dourmane, Samir, Fréchet Jachym, Mathilde, Froissart, Antoine, Giacomet, Vania, Goletti, Delia, Grard, Soazic, Gualano, Gina, Izadifar, Armine, Le Du, Damien, Marín Royo, Margarita, Mazza-Stalder, Jesica, Motta, Ilaria, Ong, Catherine Wei Min, Palmieri, Fabrizio, Rivière, Frédéric, Rodrigo, Teresa, Silva, Denise Rossato, Sánchez-Montalvá, Adrián, Saporiti, Matteo, Scarpellini, Paolo, Schlemmer, Frédéric, Spanevello, Antonio, Sumarokova, Elena, Tabernero, Eva, Tambyah, Paul Anantharajah, Tiberi, Simon, Torre, Alessandro, Visca, Dina, Zabaleta Murguiondo, Miguel, Sotgiu, Giovanni, Migliori, Giovanni Battista
• Format: Journal Article
• Language: English
• Published: England European Respiratory Society 01.07.2020
• Subjects: Adult; Aged; Agora; Antitubercular Agents - therapeutic use; Antiviral Agents - therapeutic use; Azithromycin - therapeutic use; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coinfection; Coronavirus Infections - complications; Coronavirus Infections - diagnosis; Coronavirus Infections - drug therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Emigrants and Immigrants; Female; Humans; Hydroxychloroquine - therapeutic use; Life Sciences; Lopinavir - therapeutic use; Lung - diagnostic imaging; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy; Ritonavir - therapeutic use; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis - complications; Tuberculosis - diagnosis; Tuberculosis - drug therapy; Tuberculosis, Pulmonary - complications; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - drug therapy
• ISSN: 0903-1936; 1399-3003; 1399-3003
• DOI: 10.1183/13993003.01398-2020

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate and capacity to overwhelm healthcare systems [1, 2]. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission [3–5]. Diagnostic, treatment and outcome details of 49 COVID-19 patients with concurrent or previous tuberculosis from 8 countries show varied clinical profiles https://bit.ly/369ZGGu